Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Imaging Improves Orthopedic Outcomes

By HospiMedica staff writers
Posted on 11 Mar 2005
New imaging modalities are helping clinicians to not only detect a host of orthopedic and musculoskeletal problems with more precision, but also to determine with extreme accuracy whether clinical recovery from joint, tendon, or bone damage is actually complete and not a "placebo effect.”

Radiologists evaluating patients with injured tissue are increasingly utilizing ultrasound and dedicated magnetic resonance imaging (MRI) methods that allow evaluation with tremendous detail to provide noninvasive diagnostic techniques that can now take the place of an invasive routine arthroscopy examination.

"New imaging technology may serve as objective outcome measures for orthopedic conditions, both at initial diagnosis as well as following pharmaceutical or surgical intervention," said Hollis G. More...
Potter, M.D., chief of MRI department at the Hospital for Special Surgery (New York, NY, USA).

Dr. Potter presented her results at the annual meeting of the American Academy of Orthopedic Surgeons (AAOS) in Washington (DC, USA) on February 24, 2005. "Doctors treating patients for orthopedic problems often witness a placebo effect. It's not surprising because people want to feel better, especially when orthopedic problems are hindering their daily activities,” said Dr. Potter. "With time and after treatment, patients may feel better, but sometimes the underlying biology for that patient's problem tells a very different story.”

Observable clinical outcomes such as stair climbing and walking ability are still important measures for patients who have persistent tendon or joint damage, severe arthritis, or undergone joint replacement surgery, according to Dr. Potter. She also commented that imaging technology "should be held to the same degree of rigor as any clinical outcome instrument, and should be validated with regards to accuracy and reproducibility.”

"In osteoarthritis, new imaging techniques permit early disease detection, serve as an objective outcome measure for cartilage repair procedures, and also provide a measure by which to assess disease modification with pharmaceutical intervention,” Dr. Potter said. "At the end of the clinical spectrum of osteoarthritis [arthroplasty], new imaging techniques allow for more sensitive and earlier detection of particle disease, with noninvasive and more precise quantification of bone loss, as well as detection of synovial reaction at the origin of the adverse biologic reaction.”




Related Links:
Hospital for Special Surgery

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.